Telomir Pharmaceuticals, Inc. Common Stock logo

TELOTelomir Pharmaceuticals, Inc. Common Stock

TELO Stock Price, Valuation & Chart | Telomir Pharmaceuticals, Inc. Common Stock

Compare

TELO Historical price chart

TELO Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization77.03M
PE Ratio-3.86
EPS-0.29
Trading Volume31.38K
Today's High/Low1.14/1.09
Dividend Yield0.00
52 Week High/Low2.09/0.89
Shares Outstanding68.77M
TELO Financial Statement
TELO Analyst ratings
TELO Analysis & performance metrics

TELO Company profile

Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human stem cells. It…

TELO Management team

Management
Itzchak Angel Ph.D.
Chief Scientific Advisor
Erez AminovCEO
Chairman of the Board & Chief Executive Officer
Michelle Yanez M.B.A.CFO
Chief Financial Officer, Treasurer & Secretary
Total 3 executives

TELO Frequently asked questions

What is Telomir Pharmaceuticals, Inc. Common Stock (TELO) Stock Price?

Current stock price of Telomir Pharmaceuticals, Inc. Common Stock (TELO) stock is $1.120. The stock price is +1.82% higher in the session. The intraday range can be seen from this page. Volume of Telomir Pharmaceuticals, Inc. Common Stock (TELO) stock is 31.38K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Telomir Pharmaceuticals, Inc. Common Stock (TELO) stock price going up or down today?

The stock price of Telomir Pharmaceuticals, Inc. Common Stock (TELO) can change with earnings, company news, and overall market sentiment. Telomir Pharmaceuticals, Inc. Common Stock operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Telomir Pharmaceuticals, Inc. Common Stock stock expensive at its current price?

Whether Telomir Pharmaceuticals, Inc. Common Stock looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for TELO on this page is -3.86. EPS on this page is -0.29. Compare those figures with peers and growth expectations before deciding if the current Telomir Pharmaceuticals, Inc. Common Stock price is justified.

How has the stock price of Telomir Pharmaceuticals, Inc. Common Stock (TELO) performed historically?

Historical performance for Telomir Pharmaceuticals, Inc. Common Stock (TELO) is shown on the price chart on this page. Review multi-period moves alongside volume to see how TELO reacted to past earnings and market events.

Should I buy Telomir Pharmaceuticals, Inc. Common Stock (TELO) stock, at this price?

Buying Telomir Pharmaceuticals, Inc. Common Stock (TELO) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.